Vanessa Hayes

Last updated

Vanessa Hayes
Born
Cape Town, South Africa
CitizenshipAustralia
Scientific career
Fields Cancer genomics, comparative human genomics

Vanessa Hayes is a geneticist conducting research into cancer genomics and comparative human genomics. She leads a research group at the Garvan Institute of Medical Research in Sydney Australia [1] and holds the Petre Chair of Prostate Cancer Research at the University of Sydney. [2]

Contents

Early life and education

Hayes was born in Cape Town, South Africa. She undertook BSc and Masters education at Stellenbosch University [3] In 1999 she completed PhD studies in cancer genetics at the University of Groningen, Netherlands. [4]

Career

Hayes' first research position was at Stellenbosch University, investigating genetic susceptibility to HIV/AIDS. [4] [5] Her work identified the lack of knowledge about African gene variants that hindered pharmacogenomics research, including into the efficacy of HIV treatments. [6]

In 2003 Hayes moved to Sydney, Australia, to lead research into cancer genetics at the Garvan Institute of Medical Research. She subsequently joined the Children's Cancer Institute of Australia (CCIA) [4]

In 2009 Hayes was awarded a Fulbright professional scholarship to develop her expertise in genome analysis at Penn State University, with the intention of establishing a cancer genome research program focusing on prostate cancer, at the newly established UNSW Lowy Cancer Research Centre. [7]

While at the CCIA, Hayes worked on the South African Genome Project with researchers from the University of New South Wales and Penn State University in the US to compile the genome sequences of southern Africans, including Archbishop Desmond Tutu. [8] Until this research, most human genome sequences had been derived from people of European origin. Hayes and her collaborators revealed in 2010 that the genetic diversity among people in southern Africa is greater than among other populations worldwide. [9] [10]

In 2010 Hayes joined the J. Craig Venter Institute in San Diego, California, USA, where she continued her research into human genetic diversity. [4] That year she began leading a study sequencing DNA from a skeleton of an African hunter gatherer from around 315 BC found in St Helena Bay in South Africa. The DNA identified the skeleton as being from a man who was part of a previously unknown branch of the human family tree that diverged from the common lineage shared by all humans alive today. The study highlighted the significance of southern African archaeological remains in defining human origins and was published in the journal Genome Biology and Evolution in 2014. [11] [12] [13]

In 2011 Hayes was part of a research team that released details of Tasmanian devil population genetics, part of the research efforts towards understanding the devil facial tumour disease [14] [15]

Hayes's research also includes the study of prostate cancer genetics. One aspect has been investigating the genetic causes of aggressive prostate cancer that is seen in men of African ancestry [6]

Since January 2014, Hayes has held the Petre Chair of Prostate Cancer Research at the University of Sydney. [2] [16]

Media appearances

On Tuesday 23 February 2016 ABC broadcast an episode of Catalyst entitled 'Out of Africa' which explored Hayes's comparative genomics work in southern Africa. [17]

On Tuesday 23 October 2017, Hayes appeared on SBS Insight's “DNA Surprises” episode which dealt with the complex issues around ancestry testing through online companies, and particularly the unexpected information ancestry testing can uncover. [18]

Awards and recognition

Related Research Articles

<span class="mw-page-title-main">John Shine</span> Australian biochemist and molecular biologist

John Shine is an Australian biochemist and molecular biologist. Shine and Lynn Dalgarno discovered a nucleotide sequence, called the Shine-Dalgarno sequence, necessary for the initiation of protein synthesis. He directed the Garvan Institute of Medical Research in Sydney from 1990 to 2011. From 2018 to 2022, Shine was President of the Australian Academy of Science.

<span class="mw-page-title-main">Wellcome Sanger Institute</span> British genomics research institute

The Wellcome Sanger Institute, previously known as The Sanger Centre and Wellcome Trust Sanger Institute, is a non-profit British genomics and genetics research institute, primarily funded by the Wellcome Trust.

<span class="mw-page-title-main">Human genetic variation</span> Genetic diversity in human populations

Human genetic variation is the genetic differences in and among populations. There may be multiple variants of any given gene in the human population (alleles), a situation called polymorphism.

In molecular biology, SNP array is a type of DNA microarray which is used to detect polymorphisms within a population. A single nucleotide polymorphism (SNP), a variation at a single site in DNA, is the most frequent type of variation in the genome. Around 335 million SNPs have been identified in the human genome, 15 million of which are present at frequencies of 1% or higher across different populations worldwide.

David Emil Reich is an American geneticist known for his research into the population genetics of ancient humans, including their migrations and the mixing of populations, discovered by analysis of genome-wide patterns of mutations. He is professor in the department of genetics at the Harvard Medical School, and an associate of the Broad Institute. Reich was highlighted as one of Nature's 10 for his contributions to science in 2015. He received the Dan David Prize in 2017, the NAS Award in Molecular Biology, the Wiley Prize, and the Darwin–Wallace Medal in 2019. In 2021 he was awarded the Massry Prize.

<span class="mw-page-title-main">Myriad Genetics</span> American biotechnology company

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.

<span class="mw-page-title-main">David Haussler</span> American bioinformatician

David Haussler is an American bioinformatician known for his work leading the team that assembled the first human genome sequence in the race to complete the Human Genome Project and subsequently for comparative genome analysis that deepens understanding the molecular function and evolution of the genome.

<span class="mw-page-title-main">Garvan Institute of Medical Research</span>

The Garvan Institute of Medical Research is an Australian biomedical research institute located in Darlinghurst, Sydney, New South Wales. Founded in 1963 by the Sisters of Charity as a research department of St Vincent's Hospital, it is now one of Australia's largest medical research institutions, with approximately 750 scientists, students and support staff.

<span class="mw-page-title-main">Rick Kittles</span> American geneticist

Rick Antonius Kittles is an American biologist specializing in human genetics and a Senior Vice President for Research at the Morehouse School of Medicine. He is of African-American ancestry, and achieved renown in the 1990s for his pioneering work in tracing the ancestry of African Americans via DNA testing.

Personal genomics or consumer genetics is the branch of genomics concerned with the sequencing, analysis and interpretation of the genome of an individual. The genotyping stage employs different techniques, including single-nucleotide polymorphism (SNP) analysis chips, or partial or full genome sequencing. Once the genotypes are known, the individual's variations can be compared with the published literature to determine likelihood of trait expression, ancestry inference and disease risk.

<span class="mw-page-title-main">EN2 (gene)</span> Protein-coding gene in the species Homo sapiens

Homeobox protein engrailed-2 is a protein that in humans is encoded by the EN2 gene. It is a member of the engrailed gene family.

<span class="mw-page-title-main">Whole genome sequencing</span> Determining nearly the entirety of the DNA sequence of an organisms genome at a single time

Whole genome sequencing (WGS), also known as full genome sequencing, complete genome sequencing, or entire genome sequencing, is the process of determining the entirety, or nearly the entirety, of the DNA sequence of an organism's genome at a single time. This entails sequencing all of an organism's chromosomal DNA as well as DNA contained in the mitochondria and, for plants, in the chloroplast.

Christopher Carl Goodnow is an immunology researcher and the current executive director of the Garvan Institute of Medical Research. He holds the Bill and Patricia Ritchie Foundation Chair and is a Conjoint Professor in the faculty of medicine at UNSW Sydney. He holds dual Australian and US citizenship.

<span class="mw-page-title-main">John Mattick</span> Australian molecular biologist (born 1950)

John Stanley Mattick is an Australian molecular biologist known for his efforts to assign function to non-coding DNA. Mattick was the executive director of the Garvan Institute of Medical Research from 2012 to 2018. He joined Genomics England in May 2018 as chief executive officer. In October 2019, he joined the University of New South Wales in Sydney.

<span class="mw-page-title-main">Nilanjan Chatterjee</span> Biostatistician

Nilanjan Chatterjee is a Bloomberg Distinguished Professor of Biostatistics and Genetic Epidemiology at Johns Hopkins University, with appointments in the Department of Biostatistics in the Bloomberg School of Public Health and in the Department of Oncology in the Sidney Kimmel Comprehensive Cancer Center in the Johns Hopkins School of Medicine. He was formerly the chief of the Biostatistics Branch of the National Cancer Institute's Division of Cancer Epidemiology and Genetics.

<span class="mw-page-title-main">Katherine Belov</span> Australian geneticist

Katherine Belov is an Australian geneticist, professor of comparative genomics in the School of Life and Environmental Sciences and Pro Vice Chancellor of Global Engagement at the University of Sydney. She is head of the Australasian Wildlife Genomics Group and research expert in the area of comparative genomics and immunogenetics, including Tasmanian devils and koalas, two iconic Australian species that are threatened by disease processes. Throughout her career, she has disproved the idea that marsupial immune system is primitive, characterized the South American gray short-tailed opossum's immune genes, participated in the Platypus Genome Project, led research identifying the properties of platypus venom, and identified the cause of the spread of the Tasmanian devil's contagious cancer.

Clinicogenomics, also referred to as clinical genomics, is the study of clinical outcomes with genomic data. Genomic factors have a causal effect on clinical data. Clinicogenomics uses the entire genome of a patient in order to diagnose diseases or adjust medications exclusively for that patient. Whole genome testing can detect more mutations and structural anomalies than targeted gene testing. Furthermore, targeted gene testing can only test for the diseases for which the doctor screens, whereas testing the whole genome screens for all diseases with known markers at once.

Professor Susan J. Clark is an Australian biomedical researcher in epigenetics of development and cancer. She was elected a Fellow of the Australian Academy of Science in 2015, and is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow and Research Director and Head of Genomics and Epigenetics Division at the Garvan Institute of Medical Research. Clark developed the first method for bisulphite sequencing for DNA methylation analysis and used it to establish that the methylation machinery of mammalian cells is capable of both maintenance and de novo methylation at CpNpG sites and showed is inheritable. Clark's research has advanced understanding of the role of DNA methylation, non-coding RNA and microRNA in embryogenesis, reprogramming, stem cell development and cancer and has led to the identification of epigenomic biomarkers in cancer. Clark is a founding member of the International Human Epigenome Consortium (IHEC) and President of the Australian Epigenetics Alliance (AEpiA).

References

  1. ↑ "Human Comparative and Prostate Cancer Genomics". Garvan Institute of Medical Research. Retrieved 16 August 2014.
  2. 1 2 "Professor Vanessa Hayes – The University of Sydney". Sydney.edu.au. 11 April 2013. Retrieved 16 August 2014.
  3. ↑ "Unit for Molecular Genetics | Finding Cures for Cancer". ACRF. Retrieved 16 August 2014.
  4. 1 2 3 4 "Scientist Spotlight: Meet Vanessa Hayes « JCVI Blog". Blogs.jcvi.org. 10 November 2010. Retrieved 16 August 2014.
  5. ↑ "Australian Academy of Science – SATS 2008" . Retrieved 16 August 2014.
  6. 1 2 3 "Professor Vanessa Hayes awarded for exceptional Africa-related work". Garvan Institute of Medical Research. 29 July 2013. Retrieved 16 August 2014.
  7. 1 2 "Dr Vanessa Hayes". Fulbright. Retrieved 16 August 2014.
  8. ↑ Harrell, Eben (18 February 2010). "South African Archbishop Desmond Tutu's DNA Decoded – TIME". Time. Content.time.com. Retrieved 16 August 2014.
  9. ↑ Schuster, Stephan C.; Miller, Webb; Ratan, Aakrosh; Tomsho, Lynn P.; Giardine, Belinda; Kasson, Lindsay R.; Harris, Robert S.; Petersen, Desiree C.; Zhao, Fangqing; Qi, Ji; Alkan, Can; Kidd, Jeffrey M.; Sun, Yazhou; Drautz, Daniela I.; Bouffard, Pascal; Muzny, Donna M.; Reid, Jeffrey G.; Nazareth, Lynne V.; Wang, Qingyu; Burhans, Richard; Riemer, Cathy; Wittekindt, Nicola E.; Moorjani, Priya; Tindall, Elizabeth A.; Danko, Charles G.; Teo, Wee Siang; Buboltz, Anne M.; Zhang, Zhenhai; Ma, Qianyi; et al. (2010). "Complete Khoisan and Bantu genomes from southern Africa : Article". Nature. 463 (7283): 943–947. doi:10.1038/nature08795. PMC   3890430 . PMID   20164927.
  10. ↑ "From the Kalahari to the Tasman: decoding the genetic causes of cancer (Cancer Institute NSW)". Cancerinstitute.org.au. Retrieved 16 August 2014.
  11. ↑ "Ancient human genome from southern Africa throws light on our origins". Garvan Institute. Retrieved 13 October 2014.
  12. ↑ Slezak, Michael. "Found: closest link to Eve, our universal ancestor". New Scientist. Retrieved 13 October 2014.
  13. ↑ Phillips, Nicky (30 September 2014). "Skeleton of man from ancient group of humans found in South Africa". Sydney Morning Herald. Fairfax Media. Retrieved 13 October 2014.
  14. ↑ Miller, W.; Hayes, V. M.; Ratan, A.; Petersen, D. C.; Wittekindt, N. E.; Miller, J.; Walenz, B.; Knight, J.; Qi, J.; Zhao, F.; Wang, Q.; Bedoya-Reina, O. C.; Katiyar, N.; Tomsho, L. P.; Kasson, L. M.; Hardie, R.-A.; Woodbridge, P.; Tindall, E. A.; Bertelsen, M. F.; Dixon, D.; Pyecroft, S.; Helgen, K. M.; Lesk, A. M.; Pringle, T. H.; Patterson, N.; Zhang, Y.; Kreiss, A.; Woods, G. M.; Jones, M. E.; Schuster, S. C. (27 June 2011). "Genetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil)". Proceedings of the National Academy of Sciences. 108 (30): 12348–12353. Bibcode:2011PNAS..10812348M. doi: 10.1073/pnas.1102838108 . PMC   3145710 . PMID   21709235.
  15. ↑ "Catalyst: Devil in the Detail – ABC TV Science". Abc.net.au. 18 June 2009. Retrieved 16 August 2014.
  16. ↑ "News | The University of Sydney". Sydney.edu.au. 29 November 2013. Retrieved 16 August 2014.
  17. ↑ "Catalyst: Out of Africa - ABC TV Science". www.abc.net.au. 23 February 2016. Retrieved 24 January 2018.
  18. ↑ "SBS Insight DNA surprises". www.sbs.com.au. 23 October 2017. Retrieved 24 July 2019.
  19. ↑ "BNP Paribas celebrates 125th anniversary in Australia and commits to growth for the future | Bank BNP Paribas". BNP Paribas. Bnpparibas.com. 30 May 2006. Retrieved 16 August 2014.
  20. ↑ "Dr Vanessa Hayes". AIPS. Retrieved 16 August 2014.
  21. ↑ "2011 Premier's Awards for Outstanding Cancer Research (Cancer Institute NSW)". Cancerinstitute.org.au. Retrieved 16 August 2014.
  22. ↑ "Australian Academy of Science – Awardees for 2008". 7 April 2009. Retrieved 16 August 2014.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.